Quickly
Socially
Trending
Crypto
BHARAT BIOTECH
Covaxin Booster Shot Enhances Efficacy Against Delta, Omicron Variants of COVID-19: Study
US FDA Lifts Hold on Bharat Biotech’s COVID-19 Vaccine Covaxin’s Clinical Trials in America
Bharat Biotech Consortium Gets $19 Million Funding For Development of 'Variant Proof' COVID-19 Vaccine
COVID-19 Vaccine Precaution Dose: Bharat Biotech Seeks DCGI's Permission to Conduct Covaxin Booster Trials in 2-18 Age Group
Bharat Biotech Must Address WHO's COVID-19 Vaccine Covaxin Supply Suspension to Avoid Emergency Use Listing Cancellation in Future, Says MEA
COVID-19 Vaccine: DCGI Grants Emergency Use Authorisation to ZycovD for Above 12-Year-Olds, Corbevax for Children Aged 5–12
COVID-19 in India: Bharat Biotech's 'Covaxin' Gets Emergency Use Authorisation for Children Between 6-12 Years
COVID-19 in India: Bharat Biotech Asked To Provide More Data on 'Covaxin' for Below 12-Year-Olds
Bharat Biotech to Rectify Issues Raised by WHO on COVID-19 Vaccine Covaxin Soon: Sources
No Impact of WHO Action on COVID-19 Vaccine Covaxin, Have Not Supplied to Any UN Agency, Says Bharat Biotech
Bharat Biotech Enters into Partnership with Spanish Biopharmaceutical Firm Biofabri for Tuberculosis Vaccine
Google Trends
